Epidermal Growth Factor Receptor (EGFR) Inhibitor Rash is a common dermatologic side effect associated with the use of EGFR inhibitors in cancer therapy, manifesting as acneiform eruptions primarily on the face and upper trunk. The presence of this rash is often correlated with a positive therapeutic response, but it requires management to maintain patient quality of life.